Clinical Trial Update: Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pazopanib with weekly paclitaxel for stage IV penile squamous cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Squamous Cell Carcinoma

Drugs mentioned

• Taxol (paclitaxel)
• Votrient (Pazopanib)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Penile Squamous Cell Carcinoma Stage IV | Phase 2 | Status: TERMINATED